CLPUB00387
Coriell L.L., Greene A.E., Mulivor R.A.
The human genetic mutant cell repository: list of genetic variants, chromosomal aberrations and normal cell cultures submitted to the repository. 7th edition. October 1980.
(In misc. document) Institute for Medical Research (Camden, N.J.) NIH 80-2011; pp.1-254; National Institutes of Health; Bethesda; USA (1980)

PubMed=6773986; DOI=10.1172/JCI109804; PMCID=PMC371478
Gelman B.B., Papa L., Davis M.H., Gruenstein E.
Decreased lysosomal dipeptidyl aminopeptidase I activity in cultured human skin fibroblasts in Duchenne's muscular dystrophy.
J. Clin. Invest. 65:1398-1406(1980)

PubMed=6458814; DOI=10.1073/pnas.78.10.6451; PMCID=PMC349057
Scudiero D.A., Meyer S.A., Clatterbuck B.E., Tarone R.E., Robbins J.H.
Hypersensitivity to N-methyl-N'-nitro-N-nitrosoguanidine in fibroblasts from patients with Huntington disease, familial dysautonomia, and other primary neuronal degenerations.
Proc. Natl. Acad. Sci. U.S.A. 78:6451-6455(1981)

PubMed=6782112; DOI=10.1083/jcb.88.2.329; PMCID=PMC2111753
Gelman B.B., Davis M.H., Morris R.E., Gruenstein E.
Structural changes in lysosomes from cultured human fibroblasts in Duchenne's muscular dystrophy.
J. Cell Biol. 88:329-337(1981)

PubMed=6621576; DOI=10.1016/0027-5107(83)90010-6
Tarone R.E., Scudiero D.A., Robbins J.H.
Statistical methods for in vitro cell survival assays.
Mutat. Res. 111:79-96(1983)

PubMed=6726265; DOI=10.1136/jnnp.47.4.391; PMCID=PMC1027781
Robbins J.H., Scudiero D.A., Otsuka F., Tarone R.E., Brumback R.A., Wirtschafter J.D., Polinsky R.J., Barrett S.F., Moshell A.N., Scarpinato R.G., Ganges M.B., Nee L.E., Meyer S.A., Clatterbuck B.E.
Hypersensitivity to DNA-damaging agents in cultured cells from patients with Usher's syndrome and Duchenne muscular dystrophy.
J. Neurol. Neurosurg. Psychiatry 47:391-398(1984)

CLPUB00720
Greene A.E., Mulivor R.A.
1986/1987 catalog of cell lines. NIGMS human genetic mutant cell repository. 13th edition. October 1986.
(In misc. document) Institute for Medical Research (Camden, N.J.) NIH 87-2011; pp.1-549; National Institutes of Health; Bethesda; USA (1986)

PubMed=2445735; DOI=10.1016/S0021-9258(18)47730-7
Lin P.-Y., Gruenstein E.
Identification of a defective cAMP-stimulated Cl- channel in cystic fibrosis fibroblasts.
J. Biol. Chem. 262:15345-15347(1987)

CLPUB00447
Mulivor R.A., Suchy S.F.
1992/1993 catalog of cell lines. NIGMS human genetic mutant cell repository. 16th edition. October 1992.
(In misc. document) Institute for Medical Research (Camden, N.J.) NIH 92-2011; pp.1-918; National Institutes of Health; Bethesda; USA (1992)

PubMed=7847674; DOI=10.1111/j.1749-6632.1994.tb44413.x
Etcheberrigaray R., Gibson G.E., Alkon D.L.
Molecular mechanisms of memory and the pathophysiology of Alzheimer's disease.
Ann. N. Y. Acad. Sci. 747:245-255(1994)

PubMed=8823375; DOI=10.1111/1523-1747.ep12584287
Moriwaki S.-i., Stefanini M., Lehmann A.R., Hoeijmakers J.H.J., Robbins J.H., Rapin I., Botta E., Tanganelli B., Vermeulen W., Broughton B.C., Kraemer K.H.
DNA repair and ultraviolet mutagenesis in cells from a new patient with xeroderma pigmentosum group G and Cockayne syndrome resemble xeroderma pigmentosum cells.
J. Invest. Dermatol. 107:647-653(1996)

PubMed=9804340; DOI=10.1046/j.1523-1747.1998.00391.x
Khan S.G., Levy H.L., Legerski R.J., Quackenbush E., Reardon J.T., Emmert S., Sancar A., Li L., Schneider T.D., Cleaver J.E., Kraemer K.H.
Xeroderma pigmentosum group C splice mutation associated with autism and hypoglycinemia.
J. Invest. Dermatol. 111:791-796(1998)